Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
BMC Cancer
    November 2024
  1. KASMANN L, Nieto A, Rennollet R, Gurtner R, et al
    Validation of two predictive models for survival in anaplastic thyroid cancer (ATC).
    BMC Cancer. 2024;24:1477.
    >> Share

  2. ZHANG L, Wang S, Wang L
    SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma.
    BMC Cancer. 2024;24:1480.
    >> Share

  3. XIE JB, Huang SJ, Yang TB, Wang W, et al
    Comparison of machine learning methods for Predicting 3-Year survival in elderly esophageal squamous cancer patients based on oxidative stress.
    BMC Cancer. 2024;24:1432.
    >> Share

  4. YANG R, Li T, Zhang S, Shui C, et al
    The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1434.
    >> Share

  5. LI T, Dai Y, Fu X, Cai Q, et al
    Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:1421.
    >> Share

  6. CAI M, Gou J
    Symptoms and negative emotions in patients with advanced thyroid cancer: a prospective cross-sectional study.
    BMC Cancer. 2024;24:1418.
    >> Share

  7. GUO J, Si G, Song X, Si F, et al
    Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study.
    BMC Cancer. 2024;24:1416.
    >> Share

  8. ABOOSHAHAB R, Zarkesh M, Sameni M, Akbarzadeh M, et al
    Expression of TSPAN1 and its link to thyroid nodules: one step forward on the path to thyroid tumorigenesis biomarkers.
    BMC Cancer. 2024;24:1414.
    >> Share

  9. PAN C, Ng K, Voutsinas J, Barber B, et al
    Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
    BMC Cancer. 2024;24:1406.
    >> Share

  10. ZHOU Y, Zhou J, Cai X, Ge S, et al
    Integrating (18)F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.
    BMC Cancer. 2024;24:1402.
    >> Share

  11. NIKKILA R, Hirvonen E, Haapaniemi A, Pitkaniemi J, et al
    Second primary cancers in patients with a pharyngeal index tumour: a register-based cohort study.
    BMC Cancer. 2024;24:1380.
    >> Share

  12. YANG Y, Zhang J, Yuan C, Cheng Z, et al
    Recurrent aphthous stomatitis and neoplasms of the mouth and pharynx: a two-sample Mendelian randomization study.
    BMC Cancer. 2024;24:1372.
    >> Share

  13. LI P, Zhang X, Fang Q, Du W, et al
    Sentinel lymph node biopsy in cT1-2N0 minor salivary gland cancer in oral cavity.
    BMC Cancer. 2024;24:1349.
    >> Share

    October 2024
  14. ZHANG Y, Xu W, Wu M, Li Y, et al
    Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.
    BMC Cancer. 2024;24:1330.
    >> Share

  15. TSAI YT, Chen WC, Wen YW, Lin CY, et al
    Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort study.
    BMC Cancer. 2024;24:1320.
    >> Share

  16. FU LL, Yan M, Yu X, Shao M, et al
    Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.
    BMC Cancer. 2024;24:1277.
    >> Share

  17. BILGIC S, Meral R, Sager MS, Sonmezoglu K, et al
    RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.
    BMC Cancer. 2024;24:1273.
    >> Share

  18. ZHANG Y, Meng Z, Lu M, Ruan S, et al
    Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.
    BMC Cancer. 2024;24:1265.
    >> Share

  19. GHORBANPOUR M, Salarvand S, Salarvand S, Shahsavari F, et al
    Depth of invasion and extranodal extension: the influential factors to predict survival rate of patients with oral tongue squamous cell carcinoma.
    BMC Cancer. 2024;24:1256.
    >> Share

  20. XIONG W, Xie Y, Wang D, Huang X, et al
    Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling.
    BMC Cancer. 2024;24:1236.
    >> Share

  21. THARIAT J, Pham TN, Coupey J, Clarisse B, et al
    CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels.
    BMC Cancer. 2024;24:1230.
    >> Share

  22. WANG Y, Ma K, Zhang H, Wu L, et al
    Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.
    BMC Cancer. 2024;24:1228.
    >> Share

  23. YANG MH, Chen TH, Wang HM, Hsieh JC, et al
    Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
    BMC Cancer. 2024;24:1227.
    >> Share

  24. JIN J, Guo SS, Liu LT, Wen DX, et al
    Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    BMC Cancer. 2024;24:1223.
    >> Share

  25. RZEPAKOWSKA A, Oledzka J, Daniel P, Mekarska M, et al
    Immunomodulatory role of tumor microenvironment on oncological outcomes in advanced laryngeal cancer.
    BMC Cancer. 2024;24:1219.
    >> Share

    September 2024
  26. THEODORAKI MN, Huber D, Hofmann L, Werner L, et al
    Type 2-like polarization and elevated CXCL4 secretion of monocyte derived macrophages upon internalization of plasma-derived exosomes from head and neck cancer patients.
    BMC Cancer. 2024;24:1173.
    >> Share

  27. WEIJERS JAM, Verhaegh GW, Lassche G, van Engen-van Grunsven ACH, et al
    A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
    BMC Cancer. 2024;24:1174.
    >> Share

  28. DONG L, Li Y, Song X, Sun C, et al
    SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.
    BMC Cancer. 2024;24:1165.
    >> Share

  29. YADAV J, Chaudhary A, Tripathi T, Janjua D, et al
    Exosomal transcript cargo and functional correlation with HNSCC patients' survival.
    BMC Cancer. 2024;24:1144.
    >> Share

  30. ZHU Y, Xue F
    Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.
    BMC Cancer. 2024;24:1145.
    >> Share

  31. CHEN J, Wang Y, Wu M, Yu K, et al
    Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer.
    BMC Cancer. 2024;24:1132.
    >> Share

  32. ZHANG SL, Wu ZY, Fan RX, Jia J, et al
    Managing malignant sublingual gland tumors: a single institution experience with 23 patients.
    BMC Cancer. 2024;24:1135.
    >> Share

  33. DUAN W, Wu Z, Jiang H, Liao G, et al
    Preoperative thromboelastography parameters in predicting the tumour stage of oral squamous cell carcinoma.
    BMC Cancer. 2024;24:1136.
    >> Share

  34. LIU H, Lei L, Song S, Geng X, et al
    The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis.
    BMC Cancer. 2024;24:1115.
    >> Share

  35. KERSEN J, Roach P, Chandarana S, Ronksley P, et al
    Exploring transitions in care among patients with head and neck CANCER: a multimethod study.
    BMC Cancer. 2024;24:1108.
    >> Share

  36. MACDONALD C, Fitch M, Hutcheson KA, McCulloch TM, et al
    A protocol for stakeholder engagement in head and neck cancer pragmatic trials.
    BMC Cancer. 2024;24:1109.
    >> Share

  37. HUANG J, Yu Y, Wu Z, Wu C, et al
    Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis.
    BMC Cancer. 2024;24:1104.
    >> Share

  38. YAO J, Zhao X, Chen J, Liu T, et al
    Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1101.
    >> Share

  39. SHARMA S, Mittal M, Shukla A, Khan J, et al
    Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer.
    BMC Cancer. 2024;24:1094.
    >> Share

  40. HAN D, Dong J, Wang Q, Li B, et al
    Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts.
    BMC Cancer. 2024;24:1086.
    >> Share

    August 2024
  41. HE T, Shi S, Liu Y, Zhu L, et al
    Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning.
    BMC Cancer. 2024;24:1069.
    >> Share

  42. ZHANG J, Gong J, Liu H, Zhou W, et al
    Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.
    BMC Cancer. 2024;24:1039.
    >> Share

  43. QI WX, Li S, Li H, Chen J, et al
    The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.
    BMC Cancer. 2024;24:1029.
    >> Share

  44. ZHANG C, Wang SF, Zhang YL, Teng CX, et al
    Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
    BMC Cancer. 2024;24:1012.
    >> Share

  45. PARK JO, Feng YH, Su WC, Oh DY, et al
    Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial.
    BMC Cancer. 2024;24:1006.
    >> Share

  46. SHEYKHBAHAEI N, Tameemi AHA, Koopaie M
    Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.
    BMC Cancer. 2024;24:989.
    >> Share

  47. FANG CH, Cheng YF, Lin SR, Lai WY, et al
    Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.
    BMC Cancer. 2024;24:980.
    >> Share

  48. ALARCON-SANCHEZ MA, Escoto-Vasquez LS, Heboyan A
    Salivary 8-hydroxy-2'-deoxyguanosine levels in patients with oral cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:960.
    >> Share

  49. JIANG L, Zhu J, Chen X, Wang Y, et al
    Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma.
    BMC Cancer. 2024;24:945.
    >> Share

  50. GUO LF, Rao MY, Yu YF, Lin Q, et al
    The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy.
    BMC Cancer. 2024;24:950.
    >> Share

  51. NDEMELA LM, Ottoman OM, Chitemo HD, Minja CA, et al
    Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania.
    BMC Cancer. 2024;24:932.
    >> Share

    July 2024
  52. LIANG J, Fang F, Gao X, Shi J, et al
    LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway.
    BMC Cancer. 2024;24:904.
    >> Share

  53. CHO BC, Brana I, Cirauqui B, Aksoy S, et al
    Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
    BMC Cancer. 2024;23.
    >> Share

  54. SADAFI S, Choubsaz P, Kazemeini SMM, Imani MM, et al
    Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses.
    BMC Cancer. 2024;24:885.
    >> Share

  55. HIRATA K, Yoshida K, Katada C, Watanabe A, et al
    Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.
    BMC Cancer. 2024;24:873.
    >> Share

  56. ZHONG Y, Sun R, Li W, Wang W, et al
    Risk factors for esophageal anastomotic stricture after esophagectomy: a meta-analysis.
    BMC Cancer. 2024;24:872.
    >> Share

  57. XIAO L, Liu Y, Zhang X, Nie X, et al
    Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy.
    BMC Cancer. 2024;24:860.
    >> Share

  58. DIETZE A, Neyer PJ, Speth MM, Metzler P, et al
    Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol.
    BMC Cancer. 2024;24:865.
    >> Share

  59. KY TD, Loan NT, Thinh NT, Binh MT, et al
    Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam.
    BMC Cancer. 2024;24:841.
    >> Share

  60. VIRK J, Gill J, Fekrmandi F, Iovoli A, et al
    Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2024;24:838.
    >> Share

  61. FARHADI M, Fadavi P, Mohebbi S, Taghizadeh-Hesary F, et al
    A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.
    BMC Cancer. 2024;24:832.
    >> Share

  62. NANKIVELL P, Gaunt P, Gaunt C, Sissons J, et al
    PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
    BMC Cancer. 2024;24:823.
    >> Share

  63. CHAI J, Su M, Zhang R, Li N, et al
    Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma.
    BMC Cancer. 2024;24:816.
    >> Share

  64. ZHOU B, Liu J, Yang Y, Ye X, et al
    Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.
    BMC Cancer. 2024;24:810.
    >> Share

  65. LI W, Li Y, Gao S, Huang N, et al
    Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma.
    BMC Cancer. 2024;24:795.
    >> Share

  66. LIN S, Zhou H, Chen G, Xue J, et al
    Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.
    BMC Cancer. 2024;24:797.
    >> Share

  67. CHENG Y, Song Z, Cheng J, Tang Z, et al
    JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma.
    BMC Cancer. 2024;24:793.
    >> Share

    June 2024
  68. ALIM N, Elsheikh M, Satti AA, Tabassum N, et al
    Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study.
    BMC Cancer. 2024;24:781.
    >> Share

  69. ZHANG M, Li Z, Yin Y
    Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:779.
    >> Share

  70. WONGPATTARAWORAKUL W, Choi A, Buchakjian MR, Lanzel EA, et al
    Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.
    BMC Cancer. 2024;24:766.
    >> Share

  71. HUA X, Xu F, Shi W, Long ZQ, et al
    Prognostic significance of platelet?to?albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.
    BMC Cancer. 2024;24:762.
    >> Share

  72. ATULA M, Atula T, Aro K, Irjala H, et al
    Psychosocial factors and patient and healthcare delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.
    BMC Cancer. 2024;24:760.
    >> Share

  73. HU J, Dai C, Ding Z, Pan Y, et al
    IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:759.
    >> Share

  74. HU W, Hu J, Huang Q, Gao J, et al
    Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.
    BMC Cancer. 2024;24:742.
    >> Share

  75. ZENG W, Xu W, Long W
    The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.
    BMC Cancer. 2024;24:738.
    >> Share

  76. WANG X, Liu C, Wu H, Gu Y, et al
    Basement membrane-associated gene expression as a predictor of survival in oral cancer.
    BMC Cancer. 2024;24:731.
    >> Share

  77. XU H, Yang Z, Hu W, Zhou X, et al
    CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population.
    BMC Cancer. 2024;24:729.
    >> Share

  78. XU XL, Xu JH, He JQ, Li YH, et al
    Novel prognostic nomograms for postoperative patients with oral cavity squamous cell carcinoma in the central region of China.
    BMC Cancer. 2024;24:730.
    >> Share

  79. HUANG G, Wang Y, Qin B, Zeng J, et al
    Global, regional and national burdens of Nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions.
    BMC Cancer. 2024;24:720.
    >> Share

  80. WANG Y, Li X, Gang Q, Huang Y, et al
    Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts.
    BMC Cancer. 2024;24:710.
    >> Share

  81. SUN Y, Liu Y, Li H, Tang Y, et al
    The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents.
    BMC Cancer. 2024;24:690.
    >> Share

  82. PIOREK A, Pluzanski A, Knetki-Wroblewska M, Winiarczyk K, et al
    Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.
    BMC Cancer. 2024;24:686.
    >> Share

  83. WANG L, Liu L, Cao Y, Chen X, et al
    Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.
    BMC Cancer. 2024;24:679.
    >> Share

  84. VERA R, Castro N, Labiano I, Lecumberri A, et al
    The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
    BMC Cancer. 2024;24:668.
    >> Share

    May 2024
  85. FANG Q, Yuan J, Zhang X, Dai L, et al
    Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
    BMC Cancer. 2024;24:656.
    >> Share

  86. YANG X, Zheng X, Hu S, Huang J, et al
    Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
    BMC Cancer. 2024;24:654.
    >> Share

  87. ZHENG DD, Li YY, Yuan XY, Lu JL, et al
    Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:649.
    >> Share

  88. MOU Y, Liang P, Cheng X, He X, et al
    Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
    BMC Cancer. 2024;24:646.
    >> Share

  89. ZHOU J, Wang L, Qiu T, Gao H, et al
    Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
    BMC Cancer. 2024;24:648.
    >> Share

  90. ERALP B, Sefer E
    Reference-free inferring of transcriptomic events in cancer cells on single-cell data.
    BMC Cancer. 2024;24:607.
    >> Share

  91. RONG Y, Hao Y, Wei D, Li Y, et al
    Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study.
    BMC Cancer. 2024;24:606.
    >> Share

  92. ZONG L, Liu G, He H, Huang D, et al
    Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study.
    BMC Cancer. 2024;24:605.
    >> Share

  93. WANG J, Lin J, Wang R, Tong T, et al
    Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:603.
    >> Share

  94. DU R, Fan S, Yang D, Wang X, et al
    Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
    BMC Cancer. 2024;24:596.
    >> Share

  95. LIU H, Li K, Xia J, Zhu J, et al
    Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
    BMC Cancer. 2024;24:598.
    >> Share

  96. PAN Y, Chen Z, Hong W, Huang Z, et al
    A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
    BMC Cancer. 2024;24:578.
    >> Share

  97. WU WB, Cai WL, Zou YH, You R, et al
    Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience.
    BMC Cancer. 2024;24:576.
    >> Share

  98. ZHANG X, Sun K, Gan R, Yan Y, et al
    WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical beta-catenin pathway.
    BMC Cancer. 2024;24:564.
    >> Share

  99. HUANG S, Zhang J, He P, Cui X, et al
    Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
    BMC Cancer. 2024;24:557.
    >> Share

    April 2024
  100. VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A
    Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
    BMC Cancer. 2024;24:539.
    >> Share

  101. LI C, Li M, Wei W, Wang Z, et al
    Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.
    BMC Cancer. 2024;24:534.
    >> Share

  102. DONG Z, Wang GY, Dai DY, Qin GJ, et al
    Correction: Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
    BMC Cancer. 2024;24:528.
    >> Share

  103. JIANG T, Chen C, Zhou Y, Cai S, et al
    Deep learning-assisted diagnosis of benign and malignant parotid tumors based on ultrasound: a retrospective study.
    BMC Cancer. 2024;24:510.
    >> Share

  104. SHEN J, Ma Z, Yang J, Qu T, et al
    CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
    BMC Cancer. 2024;24:511.
    >> Share

  105. JOHANSSON B, Cajander A, Ahmad A, Ohlsson-Nevo E, et al
    The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
    BMC Cancer. 2024;24:494.
    >> Share

  106. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
    Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
    BMC Cancer. 2024;24:487.
    >> Share

  107. CHEN Y, Huang Y, Chen X, Chen Z, et al
    Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2024;24:483.
    >> Share

  108. MALEKI Z, Hassanzadeh J, Ghaem H
    Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
    BMC Cancer. 2024;24:467.
    >> Share

  109. DONG Z, Wang GY, Dai DY, Qin GJ, et al
    Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
    BMC Cancer. 2024;24:466.
    >> Share

  110. ELTOHAMI Y, Suleiman A
    Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
    BMC Cancer. 2024;24:473.
    >> Share

  111. MAN Q, Li P, Fan J, Yang S, et al
    The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    BMC Cancer. 2024;24:464.
    >> Share

  112. YANG Y, Yi Y, Wang Z, Li S, et al
    A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:460.
    >> Share

  113. IDEL C, Fleckner J, Plotze-Martin K, Werner L, et al
    Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
    BMC Cancer. 2024;24:459.
    >> Share

  114. DEUTSCH F, Sais D, Keatinge N, Hill M, et al
    Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
    BMC Cancer. 2024;24:442.
    >> Share

  115. ROUTILA E, Mahran R, Salminen S, Irjala H, et al
    Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
    BMC Cancer. 2024;24:443.
    >> Share

  116. CAO X, Wang X, Song J, Su Y, et al
    Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2024;24:435.
    >> Share

  117. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
    Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
    BMC Cancer. 2024;24:430.
    >> Share

  118. WANG H, Zhang C, Li Q, Tian T, et al
    Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
    BMC Cancer. 2024;24:427.
    >> Share

  119. CHEN W, Lin G, Chen Y, Cheng F, et al
    Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
    BMC Cancer. 2024;24:418.
    >> Share

  120. AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
    Impact of age on central lymph nodes involvement in papillary thyroid cancer.
    BMC Cancer. 2024;24:423.
    >> Share

  121. LI J, Gao X, Sun X, Li H, et al
    Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
    BMC Cancer. 2024;24:416.
    >> Share

  122. AVRY F, Roseau C, Leguay Z, Brabant S, et al
    Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
    BMC Cancer. 2024;24:405.
    >> Share

  123. KRIELLAARS Y, Vermaire JA, Beugeling M, Poorter R, et al
    The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
    BMC Cancer. 2024;24:403.
    >> Share

    March 2024
  124. CUI C, Wang L, Wang X
    Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients.
    BMC Cancer. 2024;24:398.
    >> Share

  125. CHEN Y, Yin M, Zhang Y, Zhou N, et al
    Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma.
    BMC Cancer. 2024;24:359.
    >> Share

  126. DAVAATSEND O, Altannamar M, Ganbat M, Jagdagsuren U, et al
    Factors associated with recurrence in patients with oral cancer in Mongolia.
    BMC Cancer. 2024;24:356.
    >> Share

  127. FAN C, Wang X, Zheng X, Sun Y, et al
    Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
    BMC Cancer. 2024;24:321.
    >> Share

  128. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
    Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
    BMC Cancer. 2024;24:308.
    >> Share

  129. FUKUDA H, Uehara T, Nakajima T, Iwaya M, et al
    A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma.
    BMC Cancer. 2024;24:294.
    >> Share

    February 2024
  130. HU Z, Wang L, Lu M, Yang W, et al
    Protect the recurrent laryngeal nerves in US-guided microwave ablation of thyroid nodules at Zuckerkandl tubercle: a pilot study.
    BMC Cancer. 2024;24:271.
    >> Share

  131. ZHENG T, Wang L, Wang H, Tang L, et al
    Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.
    BMC Cancer. 2024;24:256.
    >> Share

  132. GONG L, Li P, Liu J, Liu Y, et al
    A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
    BMC Cancer. 2024;24:244.
    >> Share

  133. YANG Y, Tan H, Lu Y, Mei J, et al
    Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:249.
    >> Share

  134. HUANG X, Chen X, Wan G, Yang D, et al
    Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
    BMC Cancer. 2024;24:245.
    >> Share

  135. DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
    Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
    BMC Cancer. 2024;24:240.
    >> Share

  136. QIU P, Guo Q, Pan K, Lin J, et al
    Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
    BMC Cancer. 2024;24:235.
    >> Share

  137. YASSIN-KASSAB A, Chatterjee S, Khan N, Wang N, et al
    p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
    BMC Cancer. 2024;24:233.
    >> Share

  138. YU XW, She PW, Chen FC, Chen YY, et al
    Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
    BMC Cancer. 2024;24:230.
    >> Share

  139. TAN R, Zhu X, Sun Y, Yang S, et al
    The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:225.
    >> Share

  140. ALMANGUSH A, Hagstrom J, Haglund C, Kowalski LP, et al
    The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
    BMC Cancer. 2024;24:213.
    >> Share

  141. JAKSTAS T, Bartnykaite A, Padervinskis E, Vegiene A, et al
    The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
    BMC Cancer. 2024;24:214.
    >> Share

  142. WU Y, Chen W, Miao H, Xu T, et al
    SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
    BMC Cancer. 2024;24:210.
    >> Share

  143. ZHU Z, Wang W, Zha Y, Wang X, et al
    Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.
    BMC Cancer. 2024;24:184.
    >> Share

  144. LU RD, Wei ZD, Liu YX, Tian D, et al
    Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
    BMC Cancer. 2024;24:177.
    >> Share

    January 2024
  145. WEI B, Yao J, Peng C, Zhao S, et al
    Correction: Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
    BMC Cancer. 2024;24:145.
    >> Share

  146. SAKAMOTO K, Hiraoka SI, Kawamura K, Ruan P, et al
    Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer.
    BMC Cancer. 2024;24:128.
    >> Share

  147. ZHANG Y, Du H, Wang N, Wang L, et al
    An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:129.
    >> Share

  148. LV T, Liu H, Mao L, Song Y, et al
    Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1.
    BMC Cancer. 2024;24:113.
    >> Share

  149. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    BMC Cancer. 2024;24:106.
    >> Share

  150. VAN BEERS MA, Speksnijder CM, van Gils CH, Frederix GWJ, et al
    Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial.
    BMC Cancer. 2024;24:76.
    >> Share

  151. GAO Y, Wang W, Yang Y, Xu Z, et al
    An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
    BMC Cancer. 2024;24:69.
    >> Share

  152. GHASEMIAN A, Sargeran K, Khami MR, Shamshiri AR, et al
    Effects of educational interventions based on the theory of planned behavior on oral cancer-related knowledge and tobacco smoking in adults: a cluster randomized controlled trial.
    BMC Cancer. 2024;24:45.
    >> Share

  153. LIU Q, Yuan Y, Shang X, Xin L, et al
    Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.
    BMC Cancer. 2024;24:25.
    >> Share

  154. WANG C, Hou Y, Wang L, Yang Y, et al
    Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
    BMC Cancer. 2024;24:5.
    >> Share

  155. YU K, Liu S, Lin Z, Song J, et al
    Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China.
    BMC Cancer. 2024;24:24.
    >> Share

    December 2023
  156. XU H, Li W, Zhang H, Wang H, et al
    Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2023;23:1259.
    >> Share

  157. XING J, Gu Y, Song Y, Liu Q, et al
    MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
    BMC Cancer. 2023;23:1267.
    >> Share

  158. ZHOU J, Wei S, Guo X, Huang Y, et al
    Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
    BMC Cancer. 2023;23:1247.
    >> Share

  159. PARK HC, Kim H, Kim JY, Lee HY, et al
    PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
    BMC Cancer. 2023;23:1242.
    >> Share

  160. DING C, Guo Y, Zhou Y, He Y, et al
    Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).
    BMC Cancer. 2023;23:1237.
    >> Share

  161. CHE J, Zhao Y, Gu B, Li S, et al
    Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    BMC Cancer. 2023;23:1238.
    >> Share

  162. WEI B, Yao J, Peng C, Zhao S, et al
    Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
    BMC Cancer. 2023;23:1225.
    >> Share

  163. ZHAO J, Zhang S, Guo X, Li C, et al
    PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
    BMC Cancer. 2023;23:1221.
    >> Share

  164. WU S, Yuan X, Huang H, Li Y, et al
    Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
    BMC Cancer. 2023;23:1217.
    >> Share

  165. HELENE C, Conrad O, Pflumio C, Borel C, et al
    Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
    BMC Cancer. 2023;23:1209.
    >> Share

  166. WANG YJ, Xie XF, He YQ, Bao T, et al
    Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
    BMC Cancer. 2023;23:1212.
    >> Share

  167. GAO J, Lan J, Liao H, Yang F, et al
    Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
    BMC Cancer. 2023;23:1205.
    >> Share

  168. ZHENG J, Zhang H, Li S, Kang Z, et al
    Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
    BMC Cancer. 2023;23:1193.
    >> Share

    November 2023
  169. LUO J, Xiao W, Hua F, Cao Y, et al
    Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1172.
    >> Share

  170. ZHOU Q, He Q, He W, Wang C, et al
    Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
    BMC Cancer. 2023;23:1171.
    >> Share

  171. GIOTAKIS AI, Runge A, Dudas J, Glueckert R, et al
    Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report.
    BMC Cancer. 2023;23:1154.
    >> Share

  172. CUI L, Chen Z, Zeng F, Jiang X, et al
    Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
    BMC Cancer. 2023;23:1146.
    >> Share

  173. YANG Z, Zuo Q, Liu R, Wu H, et al
    Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
    BMC Cancer. 2023;23:1140.
    >> Share

  174. CHEN C, Liu Y, Yao J, Wang K, et al
    Deep learning approaches for differentiating thyroid nodules with calcification: a two-center study.
    BMC Cancer. 2023;23:1139.
    >> Share

  175. WANG H, Zhou Z, Lin W, Qian Y, et al
    MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    BMC Cancer. 2023;23:1135.
    >> Share

  176. ZHENG H, Yin X, Pan T, Tao X, et al
    Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1130.
    >> Share

  177. XU T, Zhu C, Song F, Zhang W, et al
    Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
    BMC Cancer. 2023;23:1131.
    >> Share

  178. HU J, Yan J, Chen Y, Li X, et al
    ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.
    BMC Cancer. 2023;23:1114.
    >> Share

  179. SIJBEN J, Rainey L, Peters Y, Fitzgerald RC, et al
    Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
    BMC Cancer. 2023;23:1111.
    >> Share

  180. ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al
    A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
    BMC Cancer. 2023;23:1080.
    >> Share

  181. WANG X, Yu Y, Ji Y, Ma Z, et al
    Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.
    BMC Cancer. 2023;23:1077.
    >> Share

  182. YOKOTA T, Zenda S, Kodaira T, Kiyota N, et al
    Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III
    BMC Cancer. 2023;23:1068.
    >> Share

  183. XU X, Wang W, Tian B, Zhang X, et al
    The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:1067.
    >> Share

  184. KLASEN C, Wuerdemann N, Rothbart P, Prinz J, et al
    Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
    BMC Cancer. 2023;23:1054.
    >> Share

  185. SUGAWARA K, Oka D, Hara H, Yoshii T, et al
    Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
    BMC Cancer. 2023;23:1051.
    >> Share

    October 2023
  186. ZHANG L, Zhou M, Gao X, Xie Y, et al
    Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
    BMC Cancer. 2023;23:1048.
    >> Share

  187. TSUCHIHASHI K, Ito M, Arita S, Kusaba H, et al
    Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
    BMC Cancer. 2023;23:1046.
    >> Share

  188. NATSUKI S, Tanaka H, Nishiyama M, Deguchi S, et al
    Significance of CD103(+) tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer.
    BMC Cancer. 2023;23:1011.
    >> Share

  189. LAU HC, Yuan X, Huang H, Zhang M, et al
    Fusobacterium nucleatum facilitates proliferation and autophagy by activating miR-361-3p/NUDT1 axis through oxidative stress in hypopharyngeal squamous cell carcinoma.
    BMC Cancer. 2023;23:990.
    >> Share

  190. SHENG L, Zhuang L, Yang J, Zhang D, et al
    Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
    BMC Cancer. 2023;23:988.
    >> Share

  191. MODESTO A, Tougeron D, Tremolieres P, Ronchin P, et al
    Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
    BMC Cancer. 2023;23:966.
    >> Share

  192. NIU X, Liu P, Wang X, Hu C, et al
    Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland?.
    BMC Cancer. 2023;23:968.
    >> Share

  193. ZHAO Z, Sun Y, Tang J, Yang Y, et al
    LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
    BMC Cancer. 2023;23:935.
    >> Share

    September 2023
  194. SAFI S, Ahmadzade M, Karimi S, Akbari ME, et al
    A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.
    BMC Cancer. 2023;23:924.
    >> Share

  195. WANG M, Gao M, Chen Y, Wu J, et al
    PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
    BMC Cancer. 2023;23:921.
    >> Share

  196. MA X, Pierce E, Anand H, Aviles N, et al
    Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
    BMC Cancer. 2023;23:910.
    >> Share

  197. HUANG Q, Chen J, Huang Y, Xiong Y, et al
    The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
    BMC Cancer. 2023;23:901.
    >> Share

  198. ZHANG Y, Chen Y, Chen R, Zhou H, et al
    YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
    BMC Cancer. 2023;23:882.
    >> Share

  199. XU S, Huang H, Dong H, Wang X, et al
    Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
    BMC Cancer. 2023;23:880.
    >> Share

  200. LI C, Guan R, Li W, Wei D, et al
    Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
    BMC Cancer. 2023;23:840.
    >> Share

  201. DING A, Lv H, Cao J, Wang X, et al
    Ultrasonography characteristics of cystic components in primary salivary gland tumors.
    BMC Cancer. 2023;23:833.
    >> Share

  202. SONG D, Ye Z, Chen F, Zhan L, et al
    circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.
    BMC Cancer. 2023;23:821.
    >> Share

    August 2023
  203. XIE W, Sun G, Xia J, Chen H, et al
    Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.
    BMC Cancer. 2023;23:802.
    >> Share

  204. MIN X, Zhang Z, Chen Y, Zhao S, et al
    Comparison of the effectiveness of lauromacrogol injection for ablation and microwave ablation in the treatment of predominantly cystic thyroid nodules: a multicentre study.
    BMC Cancer. 2023;23:785.
    >> Share

  205. WANG X, Sun H, Li L, Gan Z, et al
    Changing patterns of nasopharyngeal carcinoma incidence in Hong Kong: a 30-year analysis and future projections.
    BMC Cancer. 2023;23:761.
    >> Share

  206. FLOUD S, Hermon C, Simpson RF, Reeves GK, et al
    Alcohol consumption and cancer incidence in women: interaction with smoking, body mass index and menopausal hormone therapy.
    BMC Cancer. 2023;23:758.
    >> Share

  207. NAAKKA E, Wahbi W, Tiikkaja R, Juurikka K, et al
    Novel human lymph node-derived matrix supports the adhesion of metastatic oral carcinoma cells.
    BMC Cancer. 2023;23:750.
    >> Share

  208. LIN L, Almont T, Beaubrun M, Macni J, et al
    Overall survival of patients with thyroid cancer in Martinique (2008-2018).
    BMC Cancer. 2023;23:739.
    >> Share

  209. LIU Y, Han Y, Liu F, Hu D, et al
    Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial.
    BMC Cancer. 2023;23:724.
    >> Share

  210. HUANG H, Xu S, Ni S, Wang X, et al
    A nomogram for predicting lateral lymph node metastasis in cN0 unifocal papillary thyroid microcarcinoma.
    BMC Cancer. 2023;23:718.
    >> Share

    July 2023
  211. HUANG X, Chen Y, Yang H, Wang R, et al
    Preoperative serum bilirubin is an independent prognostic factor for curatively resected esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:706.
    >> Share

  212. DU Q, Wu X, Zhang K, Cao F, et al
    Correction: Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:697.
    >> Share

  213. LIU H, Jiang M, Ma F, Qin J, et al
    JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:696.
    >> Share

  214. TIAN D, Jiang KY, Yang YS, Yan HJ, et al
    Pararespiratory and paradigestive lymph node metastases in esophageal squamous cell carcinoma: predicting survival and refining the N staging system.
    BMC Cancer. 2023;23:695.
    >> Share

  215. YANG M, Zhang M, Wang Q, Guo X, et al
    Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:688.
    >> Share

  216. DU Q, Wu X, Zhang K, Cao F, et al
    Predictive and prognostic markers from endoscopic ultrasound with biopsies during definitive chemoradiation therapy in esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:681.
    >> Share

  217. DONG H, Huang Z, Yang D, Li Z, et al
    Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    BMC Cancer. 2023;23:673.
    >> Share

  218. KNIPPER K, Damanakis AI, Lyu SI, Simon AG, et al
    High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma.
    BMC Cancer. 2023;23:669.
    >> Share

  219. WANG Z, Guan W, Ma Y, Zhou X, et al
    MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/beta-catenin signaling pathway.
    BMC Cancer. 2023;23:668.
    >> Share

  220. VIENNE A, Collet L, Chevalier T, Borel C, et al
    Efficacy of second-line chemotherapy or immune checkpoint inhibitors for patients with a prolonged objective response (>/= 6 months) after first-line therapy for recurrent or metastatic head and neck squamous cell carcinoma: a retrospective study.
    BMC Cancer. 2023;23:663.
    >> Share

  221. TOPKAN E, Somay E, Yilmaz B, Pehlivan B, et al
    Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
    BMC Cancer. 2023;23:651.
    >> Share

  222. GINZAC A, Ferreira MC, Cayre A, Bouvet C, et al
    Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial.
    BMC Cancer. 2023;23:621.
    >> Share

    June 2023
  223. HSIEH MJ, Lo YS, Tsai YJ, Ho HY, et al
    FAM13A polymorphisms are associated with a specific susceptibility to clinical progression of oral cancer in alcohol drinkers.
    BMC Cancer. 2023;23:607.
    >> Share

  224. QIU J, Yang J, Yu Y, Wang Z, et al
    Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy.
    BMC Cancer. 2023;23:597.
    >> Share

  225. WANG WZ, Cao X, Bian L, Gao Y, et al
    Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma.
    BMC Cancer. 2023;23:591.
    >> Share

  226. YU B, Ma SJ, Khan M, Gill J, et al
    Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    BMC Cancer. 2023;23:572.
    >> Share

  227. HU SH, Huang MY, Chen CY, Hsieh HM, et al
    Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan.
    BMC Cancer. 2023;23:567.
    >> Share

  228. ELBERS JBW, Gunsch PA, Debets R, Keereweer S, et al
    HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
    BMC Cancer. 2023;23:541.
    >> Share

  229. DU Y, Yu X, Chang ET, Yin L, et al
    EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China.
    BMC Cancer. 2023;23:521.
    >> Share

  230. HUANG C, Wang M, Chen L, Wang H, et al
    The pretherapeutic systemic inflammation score is a prognostic predictor for elderly patients with oesophageal cancer: a case control study.
    BMC Cancer. 2023;23:505.
    >> Share

  231. ALKANDARI AS, Ho JCY, Choi SW, Thomson P, et al
    Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland.
    BMC Cancer. 2023;23:503.
    >> Share

  232. HASSID S, Krug B, Deheneffe S, Daisne JF, et al
    Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL).
    BMC Cancer. 2023;23:493.
    >> Share

    May 2023
  233. YAN S, Li FP, Jian L, Zhu HT, et al
    CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    BMC Cancer. 2023;23:477.
    >> Share

  234. AMOS A, Jiang N, Zong D, Gu J, et al
    Correction: Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
    BMC Cancer. 2023;23:462.
    >> Share

  235. YANG Z, Sun P, Dahlstrom KR, Gross N, et al
    Joint effect of human papillomavirus exposure, smoking and alcohol on risk of oral squamous cell carcinoma.
    BMC Cancer. 2023;23:457.
    >> Share

  236. WANG S, Xie L, Zhuang J, Qian Y, et al
    Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai.
    BMC Cancer. 2023;23:425.
    >> Share

  237. GAO Y, Guan L, Jia R, Xiao W, et al
    High expression of PPFIA1 in human esophageal squamous cell carcinoma correlates with tumor metastasis and poor prognosis.
    BMC Cancer. 2023;23:417.
    >> Share

  238. YE G, Zhang X, Li M, Lin Z, et al
    Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer.
    BMC Cancer. 2023;23:412.
    >> Share

  239. HUANG YY, Zhou JY, Zhan ZJ, Ke LR, et al
    Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid,
    BMC Cancer. 2023;23:410.
    >> Share

  240. AUGUSTE A, Gaete S, Michineau L, Herrmann-Storck C, et al
    Association between sexual behaviour and head and neck cancer in the French West Indies: a case-control study based on an Afro-Caribbean population.
    BMC Cancer. 2023;23:407.
    >> Share

  241. YANG H, Wang JB, Wang XK, Fan JH, et al
    Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
    BMC Cancer. 2023;23:397.
    >> Share

    April 2023
  242. LEE J, Nguyen NT, Wright J, Yeung KD, et al
    A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol.
    BMC Cancer. 2023;23:379.
    >> Share

  243. HOLMBERG D, Gottlieb-Vedi E, Hedberg J, Lindblad M, et al
    Aspirin or statin use in relation to survival after surgery for esophageal cancer: a population-based cohort study.
    BMC Cancer. 2023;23:375.
    >> Share

  244. LIU L, Lin H, Shen G, Liu Y, et al
    Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:370.
    >> Share

  245. CHEN M, Xue J, Sang Y, Jiang W, et al
    Highly sensitive droplet digital PCR for detection of RET fusion in papillary thyroid cancer.
    BMC Cancer. 2023;23:363.
    >> Share

  246. SISTONEN HJ, Ilmarinen T, Atula T, Aro K, et al
    PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy.
    BMC Cancer. 2023;23:358.
    >> Share

  247. MACQ G, Silversmit G, Verdoodt F, Van Eycken L, et al
    The epidemiology of multiple primary cancers in Belgium (2004-2017): Incidence, proportion, risk, stage and impact on relative survival estimates.
    BMC Cancer. 2023;23:349.
    >> Share

  248. RAMEZANI V, Ghadirian S, Shabani M, Boroumand MA, et al
    Efficacy of curcumin for amelioration of radiotherapy-induced oral mucositis: a preliminary randomized controlled clinical trial.
    BMC Cancer. 2023;23:354.
    >> Share

  249. ZHANG J, Lin Z, Zhou J, Huang Y, et al
    Effects of preoperative albumin-to-globulin ratio on overall survival and quality of life in esophageal cell squamous carcinoma patients: a prospective cohort study.
    BMC Cancer. 2023;23:342.
    >> Share

  250. VAN DER ZIJDEN CJ, Lagarde SM, Hermus M, Kranenburg LW, et al
    A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2.
    BMC Cancer. 2023;23:327.
    >> Share

  251. ZHANG P, Wang S, Wu JZ, Song Q, et al
    Clinical and prognostic significance of perioperative change in red cell distribution width in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:319.
    >> Share

  252. HUANG Q, Li F, Ji M, Lin L, et al
    Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study.
    BMC Cancer. 2023;23:324.
    >> Share

  253. HONG K, Yang Q, Yin H, Wei N, et al
    Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer.
    BMC Cancer. 2023;23:301.
    >> Share

    March 2023
  254. AKHTAR S, Al-Shammari A, Al-Huraiti M, Al-Anjery F, et al
    Disparities in oesophageal cancer risk by age, sex, and nativity in Kuwait:1980-2019.
    BMC Cancer. 2023;23:293.
    >> Share

  255. SAITO Y, Hamamoto Y, Hirata K, Yamasaki M, et al
    Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
    BMC Cancer. 2023;23:283.
    >> Share

  256. RODRIGUEZ-ARIETALEANIZBEASKOA , Mojas Ereno E, Arietaleanizbeaskoa MS, Grandes G, et al
    Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients.
    BMC Cancer. 2023;23:271.
    >> Share

  257. YANG J, Huang A, Yang K, Jiang K, et al
    Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial.
    BMC Cancer. 2023;23:249.
    >> Share

  258. DU Y, Yu X, Chang ET, Lian S, et al
    Pre-diagnostic anti-EBV antibodies and primary liver cancer risk: a population-based nested case-control study in southern China.
    BMC Cancer. 2023;23:250.
    >> Share

  259. PERREARD M, Florent R, Divoux J, Grellard JM, et al
    ORGAVADS: establishment of tumor organoids from head and neck squamous cell carcinoma to assess their response to innovative therapies.
    BMC Cancer. 2023;23:223.
    >> Share

  260. KAMIYA H, Komatsu S, Nishibeppu K, Ohashi T, et al
    Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
    BMC Cancer. 2023;23:218.
    >> Share

  261. TSAI YS, Chen YC, Chen TI, Lee YK, et al
    Incidence trends of oral cavity, oropharyngeal, hypopharyngeal and laryngeal cancers among males in Taiwan, 1980-2019: a population-based cancer registry study.
    BMC Cancer. 2023;23:213.
    >> Share

  262. ZHEN H, Tian J, Li G, Zhao P, et al
    Raltitrexed enhanced antitumor effect of anlotinib in human esophageal squamous carcinoma cells on proliferation, invasiveness, and apoptosis.
    BMC Cancer. 2023;23:207.
    >> Share

  263. ZHANG Y, Zhang L, Li B, Ye T, et al
    Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:197.
    >> Share

    February 2023
  264. LING F, Xu S, Li X, Sun X, et al
    Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
    BMC Cancer. 2023;23:190.
    >> Share

  265. XIAO H, Bertwistle D, Khela K, Middleton-Dalby C, et al
    Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
    BMC Cancer. 2023;23:186.
    >> Share

  266. LAM LL, Pavlakis N, Shitara K, Sjoquist KM, et al
    INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG).
    BMC Cancer. 2023;23:180.
    >> Share

  267. LING F, Xu S, Li X, Sun X, et al
    Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy.
    BMC Cancer. 2023;23:169.
    >> Share

  268. FEI Z, Hong H, Xu T, Xu Y, et al
    Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma.
    BMC Cancer. 2023;23:165.
    >> Share

  269. XU G, Yang Y, Yang J, Xiao L, et al
    Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro.
    BMC Cancer. 2023;23:162.
    >> Share

  270. HUO G, Liu W, Chen P
    Efficacy of PD-1/PD-L1 inhibitors in gastric or gastro-oesophageal junction cancer based on clinical characteristics: a meta-analysis.
    BMC Cancer. 2023;23:143.
    >> Share

  271. ZHANG Z, Xie C, Gao T, Yang Y, et al
    Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma-an exploration of surrogate endpoint.
    BMC Cancer. 2023;23:145.
    >> Share

  272. NODA Y, Ishida M, Yamaka R, Ueno Y, et al
    MMP14 expression levels accurately predict the presence of extranodal extensions in oral squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2023;23:142.
    >> Share

  273. WANG Z, Qu L, Chen Q, Zhou Y, et al
    Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer.
    BMC Cancer. 2023;23:128.
    >> Share

  274. TSAI CY, Wen YW, Lee SR, Ng SH, et al
    Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
    BMC Cancer. 2023;23:126.
    >> Share

  275. AMOS A, Jiang N, Zong D, Gu J, et al
    Depletion of SOD2 enhances nasopharyngeal carcinoma cell radiosensitivity via ferroptosis induction modulated by DHODH inhibition.
    BMC Cancer. 2023;23:117.
    >> Share

    January 2023
  276. DING Y, Chu L, Cao Q, Lei H, et al
    A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    BMC Cancer. 2023;23:45.
    >> Share

  277. SHAO S, Scholtz LU, Gendreizig S, Martinez-Ruiz L, et al
    Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes.
    BMC Cancer. 2023;23:47.
    >> Share

  278. GAO SG, Qi ZP, Qi YJ, Hou YY, et al
    Porphyromonas gingivalis predicts local recurrence after endoscopic submucosal dissection of early esophageal squamous cell carcinoma or precancerous lesion.
    BMC Cancer. 2023;23:43.
    >> Share

  279. ROOHINEJAD Z, Bahramian S, Shamsabadi FT, Sahebi R, et al
    Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma.
    BMC Cancer. 2023;23:34.
    >> Share

  280. JIA GD, Sun XS, Li XY, Liu SL, et al
    Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
    BMC Cancer. 2023;23:7.
    >> Share

    December 2022
  281. CUI Z, Du L, Wang J, Li Z, et al
    Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
    BMC Cancer. 2022;22:1354.
    >> Share

  282. CHEN TH, Pan YY, Lee TL, Wang LW, et al
    Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:1336.
    >> Share

  283. WANG A, Tan Y, Wang S, Chen X, et al
    The prognostic value of separate lymphatic invasion and vascular invasion in oesophageal squamous cell carcinoma: a meta-analysis and systematic review.
    BMC Cancer. 2022;22:1329.
    >> Share

  284. DAY F, Sridharan S, Lynam J, Gedye C, et al
    Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trial
    BMC Cancer. 2022;22:1324.
    >> Share

  285. LIU Y, Xiong R, Xiao T, Xiong L, et al
    SCARA5 induced ferroptosis to effect ESCC proliferation and metastasis by combining with Ferritin light chain.
    BMC Cancer. 2022;22:1304.
    >> Share

  286. MA Y, Chen J, Yao X, Li Z, et al
    Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1287.
    >> Share

  287. RYU YJ, Lim SY, Na YM, Park MH, et al
    Prostate-specific membrane antigen expression predicts recurrence of papillary thyroid carcinoma after total thyroidectomy.
    BMC Cancer. 2022;22:1278.
    >> Share

  288. KHALES SA, Mozaffari-Jovin S, Geerts D, Abbaszadegan MR, et al
    TWIST1 activates cancer stem cell marker genes to promote epithelial-mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1272.
    >> Share

  289. PHATAK P, Burrows WM, Creed TM, Youssef M, et al
    MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells.
    BMC Cancer. 2022;22:1265.
    >> Share

  290. LI W, Yang C, Zhao F, Li J, et al
    Combination of smoking and Epstein-Barr virus DNA is a predictor of poor prognosis for nasopharyngeal carcinoma: a long-term follow-up retrospective study.
    BMC Cancer. 2022;22:1262.
    >> Share

  291. BODEN A, Lusque A, Lodin S, Bourgouin M, et al
    Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae.
    BMC Cancer. 2022;22:1260.
    >> Share

  292. SHEN Y, Shao Y, Ruan X, Zhu L, et al
    Genetic variant in miR-17-92 cluster binding sites is associated with esophageal squamous cell carcinoma risk in Chinese population.
    BMC Cancer. 2022;22:1253.
    >> Share

  293. KANEMATSU K, Kudose Y, Utsunomiya D, Kubo K, et al
    Surveillance Strategy after Curative Resection for Oesophageal Squamous Cell Cancer Using the Hazard Function.
    BMC Cancer. 2022;22:1245.
    >> Share

  294. XU S, Huang H, Huang Y, Wang X, et al
    Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer.
    BMC Cancer. 2022;22:1246.
    >> Share

    November 2022
  295. SPRAVE T, Gkika E, Verma V, Grosu AL, et al
    Patient reported outcomes based on EQ-5D-5L questionnaires in head and neck cancer patients: a real-world study.
    BMC Cancer. 2022;22:1236.
    >> Share

  296. LUO X, Huang X, Luo J, Xiao J, et al
    Induction TPF followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locally advanced hypopharyngeal cancer: a preliminary analysis of a randomized phase 2 trial.
    BMC Cancer. 2022;22:1235.
    >> Share

  297. YANG XL, Zhang LL, Kou J, Zhou GQ, et al
    Cisplatin-based concurrent chemoradiotherapy improved the survival of locoregionally advanced nasopharyngeal carcinoma after induction chemotherapy by reducing early treatment failure.
    BMC Cancer. 2022;22:1230.
    >> Share

  298. KAO HF, Huang HC, Liao BC, Hong RL, et al
    Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis.
    BMC Cancer. 2022;22:1228.
    >> Share

  299. DUPONT M, Carlier C, Gower-Rousseau C, Barbier-Lider P, et al
    Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
    BMC Cancer. 2022;22:1219.
    >> Share

  300. CAO Y, Dong H, Li G, Wei H, et al
    Temporal and spatial characteristics of tumor evolution in a mouse model of oral squamous cell carcinoma.
    BMC Cancer. 2022;22:1209.
    >> Share

  301. WANG J, Wang N, Zheng Z, Che Y, et al
    Exosomal lncRNA HOTAIR induce macrophages to M2 polarization via PI3K/ p-AKT /AKT pathway and promote EMT and metastasis in laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:1208.
    >> Share

  302. YEH TL, Hsu MS, Hsu HY, Tsai MC, et al
    Risk of cardiovascular diseases in cancer patients: A nationwide representative cohort study in Taiwan.
    BMC Cancer. 2022;22:1198.
    >> Share

  303. YANG Y, Tang P, Ma M, Zhang H, et al
    Comparison of clinicopathological features and prognostic significance between synchronous multiple primary and solitary esophageal squamous cell carcinomas.
    BMC Cancer. 2022;22:1191.
    >> Share

  304. YANG Z, Lin H, Wang Z, Rong L, et al
    The prognostic significance of the circumferential resection margin in esophageal squamous cell carcinoma patients without neoadjuvant treatment.
    BMC Cancer. 2022;22:1180.
    >> Share

  305. KAIDA H, Yasuda T, Shiraishi O, Kato H, et al
    The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1176.
    >> Share

  306. SAWICKI CM, Janal MN, Nicholson SJ, Wu AK, et al
    Oral cancer patients experience mechanical and chemical sensitivity at the site of the cancer.
    BMC Cancer. 2022;22:1165.
    >> Share

  307. INOKAWA Y, Hayashi M, Begum S, Noordhuis MG, et al
    High-risk HPV infection-associated hypermethylated genes in oropharyngeal squamous cell carcinomas.
    BMC Cancer. 2022;22:1146.
    >> Share

  308. CARPEN T, Gille E, Hammarstedt-Nordenvall L, Hansen J, et al
    Occupational risk variation of nasopharyngeal cancer in the Nordic countries.
    BMC Cancer. 2022;22:1130.
    >> Share

  309. WANG L, Yao B, Yang J, Tian Z, et al
    Construction of a novel cuproptosis-related gene signature for predicting prognosis and estimating tumor immune microenvironment status in papillary thyroid carcinoma.
    BMC Cancer. 2022;22:1131.
    >> Share

  310. LIU SL, Li XY, Sun XS, Peng JY, et al
    Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
    BMC Cancer. 2022;22:1129.
    >> Share

  311. GU P, Ling B, Ma W, Zhang J, et al
    Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
    BMC Cancer. 2022;22:1116.
    >> Share

    October 2022
  312. SAADAAT R, Abdul-Ghafar J, Hanifi AN, Khalid S, et al
    Risk factors associated with esophageal cancers, diagnosed at tertiary level in Afghanistan: a descriptive cross-sectional study.
    BMC Cancer. 2022;22:1112.
    >> Share

  313. ALMANGUSH A, Bello IO, Elseragy A, Hagstrom J, et al
    Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
    BMC Cancer. 2022;22:1108.
    >> Share

  314. FENG Y, Wang B, Pan L, Yao B, et al
    Study protocol for artificial intelligence-assisted sponge cytology as pre-endoscopy screening for early esophegeal squmaous epithelial lesions in China.
    BMC Cancer. 2022;22:1105.
    >> Share

  315. NISHIMURA A, Yokota T, Hamauchi S, Onozawa Y, et al
    Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
    BMC Cancer. 2022;22:1101.
    >> Share

  316. SHEN Y, Huang Q, Ji M, Hsueh CY, et al
    Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas.
    BMC Cancer. 2022;22:1093.
    >> Share

  317. TANG CL, Tsai WC, Lee JY, Wang YK, et al
    Higher pre-treatment skin sympathetic nerve activity and elevated resting heart rate after chemoradiotherapy predict worse esophageal cancer outcomes.
    BMC Cancer. 2022;22:1086.
    >> Share

  318. HUNG CJ, Kang BH, Chang KM, Kang YY, et al
    Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy.
    BMC Cancer. 2022;22:1084.
    >> Share

  319. KIM SI, Woo SR, Noh JK, Lee MK, et al
    Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:1077.
    >> Share

  320. YURA M, Fukuda K, Matsuda S, Irino T, et al
    Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:1064.
    >> Share

    September 2022
  321. CUI D, Cui X, Xu X, Zhang W, et al
    Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
    BMC Cancer. 2022;22:1027.
    >> Share

  322. VOTAVA M, Bartolini R, Capkova L, Smetanova J, et al
    The expression profiles of CD47 in the tumor microenvironment of salivary gland cancers: a next step in histology-driven immunotherapy.
    BMC Cancer. 2022;22:1021.
    >> Share

  323. HUANG Q, Ye M, Li F, Lin L, et al
    Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: a 3-year follow-up retrospective study.
    BMC Cancer. 2022;22:1019.
    >> Share

  324. PIEK MW, de Boer JP, van Duijnhoven F, van der Wal JE, et al
    The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
    BMC Cancer. 2022;22:1018.
    >> Share

  325. ZHANG H, Pan E, Zhang Y, Zhao C, et al
    LncRNA RPL34-AS1 suppresses the proliferation, migration and invasion of esophageal squamous cell carcinoma via targeting miR-575/ACAA2 axis.
    BMC Cancer. 2022;22:1017.
    >> Share

  326. GORPHE P, Blanchard P, Garcia GCTE, Classe M, et al
    2011-2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France.
    BMC Cancer. 2022;22:1000.
    >> Share

  327. RADES D, Zwaan I, Cacicedo J, Bruchhage KL, et al
    Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
    BMC Cancer. 2022;22:989.
    >> Share

  328. GAO TT, Shan JH, Yang YX, Zhang ZW, et al
    Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis.
    BMC Cancer. 2022;22:992.
    >> Share

  329. AHMED S, Khan S, Qureshi MA, Bukhari U, et al
    Expressional variations of Kaiso: an association with pathological characteristics and field cancerization of OSCC.
    BMC Cancer. 2022;22:990.
    >> Share

  330. LIANG MX, Fei YJ, Yang K, Tang WJ, et al
    Potential values of circulating tumor cell for detection of recurrence in patients of thyroid cancer: a diagnostic meta-analysis.
    BMC Cancer. 2022;22:954.
    >> Share

  331. STAUDACHER JJ, Arnold A, Kuhl AA, Potzsch M, et al
    Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas.
    BMC Cancer. 2022;22:953.
    >> Share

  332. XU T, Liu X
    Oleuropein inhibits invasion of squamous cell carcinoma of the head and neck through TGF-beta1 signaling pathway.
    BMC Cancer. 2022;22:942.
    >> Share

    August 2022
  333. PENG C, Yi D, Zhou Y, Yao J, et al
    Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography.
    BMC Cancer. 2022;22:938.
    >> Share

  334. WANG C, Sun G, Wang H, Dai L, et al
    Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:932.
    >> Share

  335. LIN Z, Zeng H, Xiong W, Li J, et al
    Whether the infracardiac bursa protect right pleura during laparoscopic radical operation of Siewert type II adenocarcinoma of esophagogastric junction?
    BMC Cancer. 2022;22:927.
    >> Share

  336. HU ZY, Gou JX, Cai M, Zhang YE, et al
    Translation and validation of M.D. Anderson Symptom Inventory-Thyroid Cancer module in Chinese thyroid cancer patients: a cross-sectional and methodological study.
    BMC Cancer. 2022;22:924.
    >> Share

  337. EL MASHED S, O'Donovan TR, Kay E, O'Grady A, et al
    Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
    BMC Cancer. 2022;22:908.
    >> Share

  338. GONDHOWIARDJO SA, Adham M, Rachmadi L, Atmakusuma TD, et al
    Immune cells markers within local tumor microenvironment are associated with EBV oncoprotein in nasopharyngeal cancer.
    BMC Cancer. 2022;22:887.
    >> Share

  339. GUO SS, Chen YZ, Liu LT, Liu RP, et al
    Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:880.
    >> Share

  340. YUAN X, Yang H, Zeng F, Zhou S, et al
    Prognostic value of systemic inflammation response index in nasopharyngeal carcinoma with negative Epstein-Barr virus DNA.
    BMC Cancer. 2022;22:858.
    >> Share

  341. WANG CK, Ho CF, Niu KY, Wu CC, et al
    Risk factors for rebleeding and long-term outcomes in patients with head and neck cancer bleeding: a multicenter study.
    BMC Cancer. 2022;22:841.
    >> Share

    July 2022
  342. SUN R, Zhou Y, Cai Y, Shui C, et al
    circ_0000045 promotes proliferation, migration, and invasion of head and neck squamous cell carcinomas via regulating HSP70 and MAPK pathway.
    BMC Cancer. 2022;22:799.
    >> Share

  343. CHEN C, Luo L, Xu C, Yang X, et al
    Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes.
    BMC Cancer. 2022;22:790.
    >> Share

  344. MANDIC R, Marquardt A, Terhorst P, Ali U, et al
    The importin beta superfamily member RanBP17 exhibits a role in cell proliferation and is associated with improved survival of patients with HPV+ HNSCC.
    BMC Cancer. 2022;22:785.
    >> Share

  345. KAWATA-SHIMAMURA Y, Eguchi H, Kawabata-Iwakawa R, Nakahira M, et al
    Biomarker discovery for practice of precision medicine in hypopharyngeal cancer: a theranostic study on response prediction of the key therapeutic agents.
    BMC Cancer. 2022;22:779.
    >> Share

  346. ISSA M, Klamer BG, Mladkova N, Laliotis GI, et al
    Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort.
    BMC Cancer. 2022;22:767.
    >> Share

  347. FENG WH, Chen YY, Kuo YS, Lin KH, et al
    Prognostic factors associated with (18)FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment.
    BMC Cancer. 2022;22:768.
    >> Share

  348. LIN J, Qiu Y, Zheng X, Dai Y, et al
    The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
    BMC Cancer. 2022;22:756.
    >> Share

  349. LI J, Tang LL, Ma J
    Correction: Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:755.
    >> Share

  350. YU E, Allan AL, Sanatani M, Lewis D, et al
    Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial.
    BMC Cancer. 2022;22:746.
    >> Share

  351. CZAJKOWSKI M, Kaemmerer D, Sanger J, Sauter G, et al
    Comparative evaluation of somatostatin and CXCR4 receptor expression in different types of thyroid carcinoma using well-characterised monoclonal antibodies.
    BMC Cancer. 2022;22:740.
    >> Share

  352. GUO J, Yang Q, Wei S, Shao J, et al
    Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:745.
    >> Share

  353. PEI W, Wang C, Liao H, Chen X, et al
    MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:739.
    >> Share

    June 2022
  354. HIRAHARA N, Matsubara T, Kaji S, Hayashi H, et al
    Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
    BMC Cancer. 2022;22:718.
    >> Share

  355. ZHU J, Fang R, Pan Z, Qian X, et al
    Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:716.
    >> Share

  356. LI J, Tang LL, Ma J
    Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:714.
    >> Share

  357. ZHOU M, Yang W, Xuan Y, Zou W, et al
    A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRac
    BMC Cancer. 2022;22:710.
    >> Share

  358. ALMADORI G, Coli A, De Corso E, Mele DA, et al
    Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
    BMC Cancer. 2022;22:704.
    >> Share

  359. LIN Z, Rao W, Xiang Z, Zeng Q, et al
    Characteristics and interplay of esophageal microbiota in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:696.
    >> Share

  360. DEGUCHI S, Tanaka H, Suzuki S, Natsuki S, et al
    Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:699.
    >> Share

  361. SHAVER AL, Platek ME, Singh AK, Ma SJ, et al
    Effect of musculature on mortality, a retrospective cohort study.
    BMC Cancer. 2022;22:688.
    >> Share

  362. ZHOU G, Zhang S, Jin M, Hu S, et al
    Comprehensive analysis reveals COPB2 and RYK associated with tumor stages of larynx squamous cell carcinoma.
    BMC Cancer. 2022;22:667.
    >> Share

  363. SHI J, Wang L, Yao N, Sun L, et al
    The effect of HPV DNA and p16 status on the prognosis of patients with hypopharyngeal carcinoma: a meta-analysis.
    BMC Cancer. 2022;22:658.
    >> Share

  364. CAO Y, Han D, Yang S, Shi Y, et al
    Effects of pre-operative enteral immunonutrition for esophageal cancer patients treated with neoadjuvant chemoradiotherapy: protocol for a multicenter randomized controlled trial (point trial, pre-operative immunonutrition therapy).
    BMC Cancer. 2022;22:650.
    >> Share

  365. TSAI PC, Chien HC, Hsu PK, Hung JJ, et al
    Post-recurrence survival analysis in patients with oligo-recurrence after curative esophagectomy.
    BMC Cancer. 2022;22:637.
    >> Share

  366. MAAHS L, Ghanem AI, Gutta R, Tang A, et al
    Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
    BMC Cancer. 2022;22:626.
    >> Share

  367. LI Z, Li C, Yang D, Song J, et al
    Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2022;22:616.
    >> Share

  368. LO WC, Chang CM, Wu CY, Hsieh CH, et al
    A predictive model for advanced oropharyngeal cancer patients treated with chemoradiation.
    BMC Cancer. 2022;22:615.
    >> Share

  369. NELLIGAN NM, Bender MR, Feltus FA
    Simulating the restoration of normal gene expression from different thyroid cancer stages using deep learning.
    BMC Cancer. 2022;22:612.
    >> Share

  370. LUO QW, Gao S, Lv X, Li SJ, et al
    A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:606.
    >> Share

    May 2022
  371. ZOU X, Zhou Q, Nie Y, Gou J, et al
    Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.
    BMC Cancer. 2022;22:595.
    >> Share

  372. CAI Z, Tang B, Chen L, Lei W, et al
    Mast cell marker gene signature in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:577.
    >> Share

  373. MANN C, Berlth F, Hadzijusufovic E, Tagkalos E, et al
    Extended lower paratracheal lymph node resection during esophagectomy for cancer - safety and necessity.
    BMC Cancer. 2022;22:579.
    >> Share

  374. LIN C, Li M, Lin N, Zong J, et al
    RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:549.
    >> Share

  375. QIAN L, Ni T, Fei B, Sun H, et al
    An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma.
    BMC Cancer. 2022;22:545.
    >> Share

  376. HUO Z, Fu S, Ma C, Sheng S, et al
    Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:535.
    >> Share

  377. DOS SANTOS M, Lequesne J, Leconte A, Corbinais S, et al
    Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR).
    BMC Cancer. 2022;22:537.
    >> Share

  378. CAI M, Zheng Z, Bai Z, Ouyang K, et al
    Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers.
    BMC Cancer. 2022;22:530.
    >> Share

  379. LU XJD, Jackson E, Chew J, Nguyen S, et al
    Combined chemoradiotherapy showed improved outcome with early-stage HPV-positive oropharyngeal cancers.
    BMC Cancer. 2022;22:513.
    >> Share

  380. JIN YN, Xia TL, Mai DM, Yao JJ, et al
    The prognostic value of weight loss during radiotherapy among patients with nasopharyngeal carcinoma: a large-scale cohort study.
    BMC Cancer. 2022;22:505.
    >> Share

  381. YANG Y, Zhu L, Cheng Y, Liu Z, et al
    Three-arm phase II trial comparing camrelizumab plus chemotherapy versus camrelizumab plus chemoradiation versus chemoradiation as preoperative treatment for locally advanced esophageal squamous cell carcinoma (NICE-2 Study).
    BMC Cancer. 2022;22:506.
    >> Share

  382. QIU X, Wu H, Xu T, Xie S, et al
    Reflecting on the utility of standardized uptake values on (18)F-FDG PET in nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:495.
    >> Share

    April 2022
  383. REN L, Li P, Li Z, Chen Q, et al
    AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells.
    BMC Cancer. 2022;22:465.
    >> Share

  384. ZHANG Z, Zhang X, Yin Y, Zhao S, et al
    Integrating BRAF(V600E) mutation, ultrasonic and clinicopathologic characteristics for predicting the risk of cervical central lymph node metastasis in papillary thyroid carcinoma.
    BMC Cancer. 2022;22:461.
    >> Share

  385. HERTEL M, Hagedorn L, Schmidt-Westhausen AM, Dommisch H, et al
    Comparison of five-year survival rates among patients with oral squamous cell carcinoma with and without association with syphilis: a retrospective case-control study.
    BMC Cancer. 2022;22:454.
    >> Share

  386. IIDA M, McDaniel NK, Kostecki KL, Welke NB, et al
    AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
    BMC Cancer. 2022;22:447.
    >> Share

  387. RUITER LN, van Dijk BAC, Bruggink AH, Doornaert PAH, et al
    Association of histological features with laryngeal squamous cell carcinoma recurrences: a population-based study of 1502 patients in the Netherlands.
    BMC Cancer. 2022;22:444.
    >> Share

  388. DALHAMMAR K, Kristensson J, Falkenback D, Rasmussen BH, et al
    Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer - a comparative study of treatment strategy.
    BMC Cancer. 2022;22:434.
    >> Share

  389. LI PC, Huang RY, Yang YC, Hsieh KP, et al
    Prognostic impact of angiotensin-converting enzyme inhibitors and angiotensin receptors blockers in esophageal or gastric cancer patients with hypertension - a real-world study.
    BMC Cancer. 2022;22:430.
    >> Share

  390. WANG Q, Wu Z, Zhan T, Fang S, et al
    Retraction Note: Comparison of minimally invasive Ivor Lewis esophagectomy and left transthoracic esophagectomy in esophageal squamous cell carcinoma patients: a propensity score-matched analysis.
    BMC Cancer. 2022;22:409.
    >> Share

  391. NODA Y, Ishida M, Ueno Y, Fujisawa T, et al
    Novel pathological predictive factors for extranodal extension in oral squamous cell carcinoma: a retrospective cohort study based on tumor budding, desmoplastic reaction, tumor-infiltrating lymphocytes, and depth of invasion.
    BMC Cancer. 2022;22:402.
    >> Share

  392. NIPP RD, Shulman E, Smith M, Brown PMC, et al
    Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer.
    BMC Cancer. 2022;22:383.
    >> Share

  393. KUBOTA K, Ito R, Narita N, Tanaka Y, et al
    Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
    BMC Cancer. 2022;22:368.
    >> Share

  394. ZHANG C, Li B, Zhang L, Chen F, et al
    Clinicopathological and ultrasound features as risk stratification predictors of clinical and pathological nodal status in papillary thyroid carcinoma: a study of 748 patients.
    BMC Cancer. 2022;22:354.
    >> Share

    March 2022
  395. LIU J, Lu J, Li W
    Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    BMC Cancer. 2022;22:352.
    >> Share

  396. LEE OH, Park YM, Ko SH, Lee K, et al
    Synergistic association between underweight and type 2 diabetes on the development of laryngeal cancer: a national population-based retrospective cohort study.
    BMC Cancer. 2022;22:345.
    >> Share

  397. ZHANG X, Zhang X, Jia Q, Li H, et al
    LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    BMC Cancer. 2022;22:344.
    >> Share

  398. LIANG M, Xiao J, Chen M, Zheng B, et al
    Prognostic variables for conditional survival in patients with esophageal squamous cell carcinoma who underwent minimally invasive surgery.
    BMC Cancer. 2022;22:333.
    >> Share

  399. HUANG D, Li Y, Liu N, Zhang Z, et al
    Retraction Note: Identification of novel signaling components in N,N'-Dinitrosopiperazine-mediated metastasis of nasopharyngeal Carcinoma by quantitative phosphoproteomics.
    BMC Cancer. 2022;22:324.
    >> Share

  400. YANG F, Sun Z, Wang D, Du T, et al
    MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    BMC Cancer. 2022;22:308.
    >> Share

  401. IKAWA T, Ishihara R, Matsueda K, Konishi K, et al
    Influence of radiation dose and predicted tumor invasion depth on local recurrence after definitive chemoradiotherapy for stage 0-I esophageal squamous cell carcinoma: a propensity score-weighted, retrospective, observational study.
    BMC Cancer. 2022;22:301.
    >> Share

  402. WANG CP, Chen TC, Hsu WL, Hsiao JR, et al
    Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    BMC Cancer. 2022;22:296.
    >> Share

  403. FENG J, Wang L, Wang L, Yang X, et al
    Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:284.
    >> Share

  404. BOSCOLO-RIZZO P, D'Alessandro A, Polesel J, Borsetto D, et al
    Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2022;22:243.
    >> Share

  405. PRUIJSSEN JT, Wenmakers A, Kessels RPC, Piai V, et al
    Long-term cognitive, psychosocial, and neurovascular complications of unilateral head and neck irradiation in young to middle-aged adults.
    BMC Cancer. 2022;22:244.
    >> Share

  406. CHENG J, Zhang R, Yan M, Li Y, et al
    Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:238.
    >> Share

  407. MIDORIKAWA S, Ohtsuru A
    Young people's perspectives of thyroid cancer screening and its harms after the nuclear accident in Fukushima Prefecture: a questionnaire survey indicating opt-out screening strategy of the thyroid examination as an ethical issue.
    BMC Cancer. 2022;22:235.
    >> Share

  408. KOSKINEN AI, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in oral and pharyngeal cancers in Finland and Sweden through half century.
    BMC Cancer. 2022;22:227.
    >> Share

    February 2022
  409. WANG X, Hu B, Chen J, Xie F, et al
    Risk factors of esophageal fistula induced by re-radiotherapy for recurrent esophageal cancer with local primary site.
    BMC Cancer. 2022;22:207.
    >> Share

  410. YE L, Hu L, Liu W, Luo Y, et al
    Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2022;22:194.
    >> Share

  411. FAN X, Huang Y, Xu P, Min Y, et al
    Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
    BMC Cancer. 2022;22:178.
    >> Share

  412. HSIEH CY, Lien MY, Lin CY, Lo WJ, et al
    Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial.
    BMC Cancer. 2022;22:169.
    >> Share

  413. VEEN AV, Schiffmann LM, de Groot EM, Bartella I, et al
    The ISCON-trial protocol: laparoscopic ischemic conditioning prior to esophagectomy in patients with esophageal cancer and arterial calcifications.
    BMC Cancer. 2022;22:144.
    >> Share

    January 2022
  414. WU LL, Zhong JD, Zhu JL, Kang L, et al
    Postoperative survival effect of the number of examined lymph nodes on esophageal squamous cell carcinoma with pathological stage T1-3N0M0.
    BMC Cancer. 2022;22:118.
    >> Share

  415. ZANG Z, Liu Y, Wang J, Liu Y, et al
    Dietary patterns and severity of symptom with the risk of esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional latent class analysis.
    BMC Cancer. 2022;22:95.
    >> Share

  416. UENO T, Yatsuoka W, Ishiki H, Miyano K, et al
    Effects of an oral mucosa protective formulation on chemotherapy- and/or radiotherapy-induced oral mucositis: a prospective study.
    BMC Cancer. 2022;22:90.
    >> Share

  417. BUCKLE GC, Mrema A, Mwachiro M, Ringo Y, et al
    Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study.
    BMC Cancer. 2022;22:82.
    >> Share

  418. GILLMAN A, Hayes M, Sheaf G, Walshe M, et al
    Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review.
    BMC Cancer. 2022;22:53.
    >> Share

  419. SCHLINTL V, Huemer F, Rinnerthaler G, Melchardt T, et al
    Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort.
    BMC Cancer. 2022;22:51.
    >> Share

  420. LIN C, Lin S, Zhu L, Lin S, et al
    Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
    BMC Cancer. 2022;22:35.
    >> Share

  421. ROSENBERG AJ, Izumchenko E, Pearson A, Gooi Z, et al
    Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
    BMC Cancer. 2022;22:17.
    >> Share

  422. HENNESSY MA, Hamid M, Keegan NM, Corrigan L, et al
    Metastatic gastroesophageal cancer in older patients - is this patient cohort represented in clinical trials?
    BMC Cancer. 2022;22:3.
    >> Share

    December 2021
  423. HUANG B, Chan EG, Pennathur A, Luketich JD, et al
    The ideal approach for treatment of cT1N+ and cT2Nany esophageal cancer.: a NCDB analysis.
    BMC Cancer. 2021;21:1334.
    >> Share

  424. XIAO L, Hu Q, Peng Y, Zheng K, et al
    TRAP1 suppresses oral squamous cell carcinoma progression by reducing oxidative phosphorylation metabolism of Cancer-associated fibroblasts.
    BMC Cancer. 2021;21:1329.
    >> Share

  425. OU D, Wu Y
    The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1327.
    >> Share

  426. LIU LT, Guo SS, Li H, Lin C, et al
    Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1320.
    >> Share

  427. WUSHOU A, Yibulayin F, Sheng L, Luo Y, et al
    Elective neck dissection improves the survival of patients with T2N0M0 oral squamous cell carcinoma: a study of the SEER database.
    BMC Cancer. 2021;21:1309.
    >> Share

  428. XU N, Lu M, Wang J, Li Y, et al
    Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway.
    BMC Cancer. 2021;21:1307.
    >> Share

  429. ZOUHRY Y, Taibi A, Durand-Fontanier S, Darbas T, et al
    Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
    BMC Cancer. 2021;21:1313.
    >> Share

  430. REN JL, Rojo RD, Perez JVD, Yeung SJ, et al
    Variations in pain prevalence, severity, and analgesic use by duration of survivorship: a cross-sectional study of 505 post-treatment head and neck cancer survivors.
    BMC Cancer. 2021;21:1304.
    >> Share

  431. PU Y, Li Q, Wang Y, Xu L, et al
    pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
    BMC Cancer. 2021;21:1283.
    >> Share

    November 2021
  432. SUNDE B, Lindblad M, Malmstrom M, Hedberg J, et al
    Health-related quality of life one year after the diagnosis of oesophageal cancer: a population-based study from the Swedish National Registry for Oesophageal and Gastric Cancer.
    BMC Cancer. 2021;21:1277.
    >> Share

  433. ZONG JF, Liang QD, Lu QJ, Liu YH, et al
    Comparison of radiotherapy combined with nimotuzumab vs. chemoradiotherapy for locally recurrent nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1274.
    >> Share

  434. YE L, Hu L, Liu W, Luo Y, et al
    Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
    BMC Cancer. 2021;21:1250.
    >> Share

  435. ZHANG Y, Chen M, Liu Z, Wang X, et al
    The neuropeptide calcitonin gene-related peptide links perineural invasion with lymph node metastasis in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:1254.
    >> Share

  436. BALK M, Rupp R, Mantsopoulos K, Allner M, et al
    Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    BMC Cancer. 2021;21:1236.
    >> Share

  437. MCILVANNA E, Linden GJ, Craig SG, Lundy FT, et al
    Fusobacterium nucleatum and oral cancer: a critical review.
    BMC Cancer. 2021;21:1212.
    >> Share

  438. LI J, Yan T, Wu X, Ke X, et al
    Aberrant overexpression of transcription factor Forkhead box D1 predicts poor prognosis and promotes cancer progression in HNSCC.
    BMC Cancer. 2021;21:1205.
    >> Share

  439. ZHU X, Shanzhou Q, Li D, Pang X, et al
    PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis.
    BMC Cancer. 2021;21:1195.
    >> Share

  440. SHI K, Zhang JZ, Yang L, Li NN, et al
    Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1196.
    >> Share

  441. NAGAKI Y, Motoyama S, Sato Y, Wakita A, et al
    Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    BMC Cancer. 2021;21:1192.
    >> Share

  442. SUZUKI H, Sasaki E, Takano G, Goto S, et al
    Lymph node ratio as a predictor for minor salivary gland cancer in head and neck.
    BMC Cancer. 2021;21:1186.
    >> Share

  443. CHEN S, Lai H, Zhao J, Chen B, et al
    The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy.
    BMC Cancer. 2021;21:1183.
    >> Share

    October 2021
  444. ZHU Y, Yao W, Xu BC, Lei YY, et al
    Predicting response to immunotherapy plus chemotherapy in patients with esophageal squamous cell carcinoma using non-invasive Radiomic biomarkers.
    BMC Cancer. 2021;21:1167.
    >> Share

  445. ROSVALL BR, Kostiuk M, Williams J, Matkin A, et al
    Utility of droplet digital polymerase chain reaction for TERT and BRAF mutational profiling of thyroid nodules.
    BMC Cancer. 2021;21:1142.
    >> Share

  446. CHEN Y, Huang Q, Chen J, Lin Y, et al
    Primary gross tumor volume is prognostic and suggests treatment in upper esophageal cancer.
    BMC Cancer. 2021;21:1130.
    >> Share

  447. KASSIR ZM, Li J, Harrison C, Johnson JT, et al
    Disparity of perception of quality of life between head and neck cancer patients and caregivers.
    BMC Cancer. 2021;21:1127.
    >> Share

  448. MERINO T, Pinto MP, Orellana MP, Martinez G, et al
    Multimodal assessment of acute cardiac toxicity induced by thoracic radiotherapy in cancer patients. Study protocol.
    BMC Cancer. 2021;21:1114.
    >> Share

  449. MARTINO R, Fitch MI, Fuller CD, Hope A, et al
    The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
    BMC Cancer. 2021;21:1100.
    >> Share

  450. ZHANG QW, Wang JY, Qiao XF, Li TL, et al
    Variations in disease burden of laryngeal cancer attributable to alcohol use and smoking in 204 countries or territories, 1990-2019.
    BMC Cancer. 2021;21:1082.
    >> Share

  451. ZHOU Y, Zhang S, Min Z, Yu Z, et al
    Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    BMC Cancer. 2021;21:1085.
    >> Share

  452. MUHANNA N, Eu D, Chan HHL, Douglas C, et al
    Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    BMC Cancer. 2021;21:1075.
    >> Share

  453. HUANG Q, Shen YJ, Hsueh CY, Guo Y, et al
    miR-17-5p drives G2/M-phase accumulation by directly targeting CCNG2 and is related to recurrence of head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1074.
    >> Share

    September 2021
  454. LV X, Han S, Xu B, Deng Y, et al
    The value of complete blood count for the prognosis analysis of preoperative esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:1072.
    >> Share

  455. AUGUSTE A, Joachim C, Deloumeaux J, Gaete S, et al
    Head and neck cancer risk factors in the French West Indies.
    BMC Cancer. 2021;21:1071.
    >> Share

  456. KAWASHITA Y, Kitamura M, Soutome S, Ukai T, et al
    Association of neutrophil-to-lymphocyte ratio with severe radiation-induced mucositis in pharyngeal or laryngeal cancer patients: a retrospective study.
    BMC Cancer. 2021;21:1064.
    >> Share

  457. CHENG S, Yang L, Dai X, Wang J, et al
    The risk and prognostic factors for brain metastases in esophageal cancer patients: an analysis of the SEER database.
    BMC Cancer. 2021;21:1057.
    >> Share

  458. TAGKALOS E, van der Sluis PC, Berlth F, Poplawski A, et al
    Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal adenocarcinoma, a randomized controlled trial (ROBOT-2 trial).
    BMC Cancer. 2021;21:1060.
    >> Share

  459. SHI C, Liu S, Tian X, Wang X, et al
    A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:1035.
    >> Share

  460. NIU C, Liu Y, Wang J, Liu Y, et al
    Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study.
    BMC Cancer. 2021;21:1034.
    >> Share

  461. TANIYAMA Y, Murakami K, Yoshida N, Takahashi K, et al
    Evaluating the effect of Neoadjuvant chemotherapy for esophageal Cancer using the RECIST system with shorter-axis measurements: a retrospective multicenter study.
    BMC Cancer. 2021;21:1008.
    >> Share

  462. XIA T, Tian H, Zhang K, Zhang S, et al
    Exosomal ERp44 derived from ER-stressed cells strengthens cisplatin resistance of nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:1003.
    >> Share

  463. WANG Y, Wang J, Chen Z, Ma M, et al
    Analysis of the correlation between high iodized salt intake and the risk of thyroid nodules: a large retrospective study.
    BMC Cancer. 2021;21:1000.
    >> Share

  464. LI R, Pang XF, Huang ZG, Yang LH, et al
    Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
    BMC Cancer. 2021;21:996.
    >> Share

  465. WANG ZY, Jiang YZ, Xiao W, Xue XB, et al
    Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.
    BMC Cancer. 2021;21:988.
    >> Share

  466. ISHIZU T, Eichin D, Padzik A, Tuominen S, et al
    Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9.
    BMC Cancer. 2021;21:990.
    >> Share

  467. KHAIRAN P, Sobue T, Eshak ES, Zha L, et al
    Association of dietary intakes of vitamin B12, vitamin B6, folate, and methionine with the risk of esophageal cancer: the Japan Public Health Center-based (JPHC) prospective study.
    BMC Cancer. 2021;21:982.
    >> Share

  468. CHEN YH, Chen CH, Chien CY, Su YY, et al
    Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
    BMC Cancer. 2021;21:979.
    >> Share

    August 2021
  469. MINESAKI A, Kai K, Kuratomi Y, Aishima S, et al
    Infiltration of CD1a-positive dendritic cells in advanced laryngeal cancer correlates with unfavorable outcomes post-laryngectomy.
    BMC Cancer. 2021;21:973.
    >> Share

  470. MU G, Wang J, Liu Z, Zhang H, et al
    Association between smokeless tobacco use and oral cavity cancer risk in women compared with men: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:960.
    >> Share

  471. LIU Z, Liu H, Dong Q, Li H, et al
    Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
    BMC Cancer. 2021;21:951.
    >> Share

  472. LI G, Xia YF, Huang YX, Okat D, et al
    Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
    BMC Cancer. 2021;21:944.
    >> Share

  473. FENG G, Xu Y, Ma N, Midorikawa K, et al
    Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:929.
    >> Share

  474. LI X, Liu Z, Zhou W, Liu X, et al
    Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
    BMC Cancer. 2021;21:922.
    >> Share

  475. LI MX, Sun XM, Cheng WG, Ruan HJ, et al
    Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:906.
    >> Share

  476. FUJIMA N, Andreu-Arasa VC, Meibom SK, Mercier GA, et al
    Prediction of the local treatment outcome in patients with oropharyngeal squamous cell carcinoma using deep learning analysis of pretreatment FDG-PET images.
    BMC Cancer. 2021;21:900.
    >> Share

  477. MASAKI C, Sugino K, Kobayashi S, Hosoi Y, et al
    Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:894.
    >> Share

  478. ZAHID N, Zahid W, Khalid W, Azam I, et al
    Resilience and its associated factors in head and neck cancer patients in Pakistan: an analytical cross-sectional study.
    BMC Cancer. 2021;21:888.
    >> Share

    July 2021
  479. HE Y, Liu Z, Sheng S, Gao W, et al
    Salvage surgery for patients with residual/persistent diseases after improper or insufficient treatment of oral squamous cell carcinoma: can we rectify these mistakes?
    BMC Cancer. 2021;21:878.
    >> Share

  480. ROUTILA J, Suvila K, Grenman R, Leivo I, et al
    Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:868.
    >> Share

  481. SINGH P, Bennett B, Bailey T, Taylor-Stokes G, et al
    Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in Europe.
    BMC Cancer. 2021;21:854.
    >> Share

  482. CHEN W, Luo YK, Zhang Y, Song Q, et al
    Ultrasound-guided implantation of radioactive (125)I seed in radioiodine refractory differentiated thyroid carcinoma.
    BMC Cancer. 2021;21:834.
    >> Share

  483. ZHU C, Gu L, Liu Z, Li J, et al
    Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:836.
    >> Share

  484. LI H, Zhang X, Yi C, He Y, et al
    Ferroptosis-related gene signature predicts the prognosis in Oral squamous cell carcinoma patients.
    BMC Cancer. 2021;21:835.
    >> Share

  485. LANG K, Adeberg S, Harrabi S, Held T, et al
    Adenoid cystic Carcinoma and Carbon ion Only irradiation (ACCO): Study protocol for a prospective, open, randomized, two-armed, phase II study.
    BMC Cancer. 2021;21:812.
    >> Share

  486. STRAUB M, Sigman DM, Auderset A, Ollivier J, et al
    Distinct nitrogen isotopic compositions of healthy and cancerous tissue in mice brain and head&neck micro-biopsies.
    BMC Cancer. 2021;21:805.
    >> Share

  487. ZHOU YJ, Lu XF, Meng JL, Wang XY, et al
    Neo-adjuvant radiation therapy provides a survival advantage in T3-T4 nodal positive gastric and gastroesophageal junction adenocarcinoma: a SEER database analysis.
    BMC Cancer. 2021;21:771.
    >> Share

    June 2021
  488. HE G, Pang R, Han J, Jia J, et al
    TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
    BMC Cancer. 2021;21:753.
    >> Share

  489. ITO T, Tsukahara K, Sato H, Shimizu A, et al
    Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise.
    BMC Cancer. 2021;21:742.
    >> Share

  490. MIYAWAKI Y, Sato H, Oya S, Sugita H, et al
    Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study.
    BMC Cancer. 2021;21:725.
    >> Share

  491. LIU C, Zhou X, Pan Y, Liu Y, et al
    Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis.
    BMC Cancer. 2021;21:722.
    >> Share

  492. SANTERO M, Perez-Bracchiglione J, Acosta-Dighero R, Meade AG, et al
    Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
    BMC Cancer. 2021;21:712.
    >> Share

  493. BAKOS B, Kiss A, Arvai K, Szili B, et al
    Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
    BMC Cancer. 2021;21:706.
    >> Share

  494. SHI Y, Yang D, Qin Y
    Identifying prognostic lncRNAs based on a ceRNA regulatory network in laryngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:705.
    >> Share

  495. UEHARA K, Tanabe Y, Hirota S, Higa S, et al
    Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    BMC Cancer. 2021;21:688.
    >> Share

  496. FU JY, Zhang CP, Zhang ZY
    Tracking the dropout patients of neoadjuvant chemotherapy with locally advanced oral cavity cancer.
    BMC Cancer. 2021;21:663.
    >> Share

  497. DRAGAN T, Duprez F, Van Gossum A, Gulyban A, et al
    Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
    BMC Cancer. 2021;21:656.
    >> Share

  498. HOXHAJ I, Vukovic V, Boccia S, Pastorino R, et al
    Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.
    BMC Cancer. 2021;21:660.
    >> Share

  499. CHEN WJ, Xu WN, Wang HY, Chen XX, et al
    Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population.
    BMC Cancer. 2021;21:651.
    >> Share

    May 2021
  500. LIU W, Yu B, Luo Y, Li J, et al
    Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model.
    BMC Cancer. 2021;21:639.
    >> Share

  501. HEFT NEAL ME, Birkeland AC, Bhangale AD, Zhai J, et al
    Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene.
    BMC Cancer. 2021;21:636.
    >> Share

  502. LI X, Fang Q, Du W, Zhang X, et al
    Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:622.
    >> Share

  503. MUKHERJEE K, Sur D, Singh A, Rai S, et al
    Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    BMC Cancer. 2021;21:628.
    >> Share

  504. FANG X, Wang S, Zhao J, Zhang Y, et al
    A population-based analysis of clinical features and lymph node dissection in head and neck malignant neurogenic tumors.
    BMC Cancer. 2021;21:598.
    >> Share

  505. CHEN Y, Hu N, Liao L, Yu K, et al
    ABO genotypes and the risk of esophageal and gastric cancers.
    BMC Cancer. 2021;21:589.
    >> Share

  506. O'CONNOR L, Smyth E, Bennett AE, Smith V, et al
    Identifying outcomes reported in exercise interventions in oesophagogastric cancer survivors: a systematic review.
    BMC Cancer. 2021;21:586.
    >> Share

  507. MAGHSOOMI Z, Emami Z, Malboosbaf R, Malek M, et al
    Efficacy and safety of peptide receptor radionuclide therapy in advanced radioiodine-refractory differentiated thyroid cancer and metastatic medullary thyroid cancer: a systematic review.
    BMC Cancer. 2021;21:579.
    >> Share

  508. QUINTANILHA JCF, Cursino MA, Borges JB, Torso NG, et al
    MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.
    BMC Cancer. 2021;21:575.
    >> Share

  509. QIN M, Han F, Wu J, Gao FX, et al
    KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPbeta transcription.
    BMC Cancer. 2021;21:559.
    >> Share

  510. GURIZZAN C, Lorini L, Paderno A, Tomasoni M, et al
    Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial.
    BMC Cancer. 2021;21:561.
    >> Share

  511. MEI X, Yao X, Feng F, Cheng W, et al
    Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients.
    BMC Cancer. 2021;21:543.
    >> Share

  512. BEYENE ET, Ketema SG, Alebachew AN, Saleh MY, et al
    Descriptive epidemiology of nasopharyngeal carcinoma at Tikur Anbessa Hospital, Ethiopia.
    BMC Cancer. 2021;21:540.
    >> Share

  513. YANG JH, Sun XS, Xiao BB, Liu LT, et al
    Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
    BMC Cancer. 2021;21:534.
    >> Share

  514. CHEN J, Xia YJ, Liu TY, Lai YH, et al
    Development and validation of a survival nomogram for patients with Siewert type II/III adenocarcinoma of the esophagogastric junction based on real-world data.
    BMC Cancer. 2021;21:532.
    >> Share

  515. XU Y, Wu Z, Ye W, Xiao Y, et al
    Prognostic value of serum uric acid and tumor response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    BMC Cancer. 2021;21:519.
    >> Share

  516. ARSA L, Siripoon T, Trachu N, Foyhirun S, et al
    Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    BMC Cancer. 2021;21:504.
    >> Share

    April 2021
  517. ALMANGUSH A, Alabi RO, Troiano G, Coletta RD, et al
    Clinical significance of tumor-stroma ratio in head and neck cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:480.
    >> Share

  518. ZHANG X, Song X, Lai Y, Zhu B, et al
    Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis.
    BMC Cancer. 2021;21:483.
    >> Share

  519. KUNZ V, Wichmann G, Lehmann-Laue A, Mehnert-Theuerkauf A, et al
    Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.
    BMC Cancer. 2021;21:478.
    >> Share

  520. JENSEN CB, Saucke MC, Pitt SC
    Active surveillance for thyroid Cancer: a qualitative study of barriers and facilitators to implementation.
    BMC Cancer. 2021;21:471.
    >> Share

  521. WONG TJ, Li Q, Dodd V, Wang W, et al
    Oral cancer knowledge and screening behavior among smokers and non-smokers in rural communities.
    BMC Cancer. 2021;21:430.
    >> Share

  522. DUAN X, Shang X, Yue J, Ma Z, et al
    A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:431.
    >> Share

  523. ZHOU LQ, Hu Y, Xiao HJ
    The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:424.
    >> Share

  524. DING Y, Jiang R, Chen Y, Jing J, et al
    Comparing the characteristics and predicting the survival of patients with head and neck melanoma versus body melanoma: a population-based study.
    BMC Cancer. 2021;21:420.
    >> Share

  525. WEI M, Zhao L, Lv J, Li X, et al
    The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma.
    BMC Cancer. 2021;21:415.
    >> Share

  526. BOGUSZEWICZ L, Bielen A, Jarczewski JD, Ciszek M, et al
    Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics.
    BMC Cancer. 2021;21:410.
    >> Share

  527. SAENTHAVEESUK P, Yang L, Zeng B, Xu M, et al
    Development and validation of multiparametric MRI-based nomogram for predicting occult metastasis risk in early tongue squamous cell carcinoma.
    BMC Cancer. 2021;21:408.
    >> Share

  528. WANG Y, Zhang X, Zhang X, Liu-Helmersson J, et al
    Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients.
    BMC Cancer. 2021;21:403.
    >> Share

  529. ZHOU Z, Wu W, Li J, Liu C, et al
    Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma.
    BMC Cancer. 2021;21:395.
    >> Share

  530. BERNADACH M, Lapeyre M, Dillies AF, Miroir J, et al
    Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers.
    BMC Cancer. 2021;21:360.
    >> Share

  531. NIE Z, Zhao P, Shang Y, Sun B, et al
    Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection.
    BMC Cancer. 2021;21:372.
    >> Share

  532. ZHU Q, Xu D
    Correlation between preoperative ultrasonic features of medullary thyroid carcinoma and postoperative recurrence.
    BMC Cancer. 2021;21:344.
    >> Share

  533. ZHENG W, Chen C, Yu J, Jin C, et al
    An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma.
    BMC Cancer. 2021;21:345.
    >> Share

    March 2021
  534. CHOI KH, Song JH, Park EY, Hong JH, et al
    Analysis of PET parameters as prognosticators of survival and tumor extent in Oropharyngeal Cancer treated with surgery and postoperative radiotherapy.
    BMC Cancer. 2021;21:317.
    >> Share

  535. PHAM DX, Nguyen HD, Phung AHT, Bui TD, et al
    Trends in incidence and histological pattern of thyroid cancer in Ho Chi Minh City, Vietnam (1996-2015): a population-based study.
    BMC Cancer. 2021;21:296.
    >> Share

  536. LI C, Tao C, Bai T, Li Z, et al
    Beam complexity and monitor unit efficiency comparison in two different volumetric modulated arc therapy delivery systems using automated planning.
    BMC Cancer. 2021;21:261.
    >> Share

  537. ZHANG S, Zhang R, Wang C, Gong W, et al
    Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth.
    BMC Cancer. 2021;21:225.
    >> Share

    February 2021
  538. CHOI SY, Lee E, Kim E, Chung MK, et al
    Clinical outcomes of bulky parotid gland cancers: need for self-examination and screening program for early diagnosis of parotid tumors.
    BMC Cancer. 2021;21:178.
    >> Share

  539. WENTER V, Albert NL, Ahmaddy F, Unterrainer M, et al
    The diagnostic challenge of coexistent sarcoidosis and thyroid cancer - a retrospective study.
    BMC Cancer. 2021;21:139.
    >> Share

  540. LIANG YJ, Mei XY, Zeng B, Zhang SE, et al
    Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
    BMC Cancer. 2021;21:122.
    >> Share

    January 2021
  541. KONDO S, Hirakawa H, Ikegami T, Uehara T, et al
    Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2021;21:87.
    >> Share

  542. SOLIS-PAZMINO P, Salazar-Vega J, Lincango-Naranjo E, Garcia C, et al
    Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    BMC Cancer. 2021;21:42.
    >> Share

    December 2020
  543. KATAGIRI T, Ohyama Y, Miyamoto H, Egawa Y, et al
    Pathological responses to low-dose irradiation and Pepleomycin in Oral squamous cell carcinoma are predictive of Locoregional control.
    BMC Cancer. 2020;20:1216.
    >> Share

  544. DATAR S, Cabanillas M, Dadu R, Ost D, et al
    Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents.
    BMC Cancer. 2020;20:1181.
    >> Share

    November 2020
  545. KALISZEWSKI K, Diakowska D, Nowak L, Wojtczak B, et al
    The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
    BMC Cancer. 2020;20:1166.
    >> Share

  546. XIE Z, Li X, He Y, Wu S, et al
    Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
    BMC Cancer. 2020;20:1143.
    >> Share

  547. KANG HY, Kim I, Kim YY, Bahk J, et al
    Income differences in screening, incidence, postoperative complications, and mortality of thyroid cancer in South Korea: a national population-based time trend study.
    BMC Cancer. 2020;20:1096.
    >> Share

    October 2020
  548. GU B, Fang Q, Wu Y, Du W, et al
    Impact of submandibular gland preservation in neck management of early-stage buccal squamous cell carcinoma on locoregional control and disease-specific survival.
    BMC Cancer. 2020;20:1034.
    >> Share

  549. HOSHINO I, Nabeya Y, Takiguchi N, Gunji H, et al
    Inducing multiple antibodies to treat squamous cell esophageal carcinoma.
    BMC Cancer. 2020;20:1007.
    >> Share

  550. AN YZ, Cho E, Ling J, Zhang X, et al
    The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma.
    BMC Cancer. 2020;20:987.
    >> Share

  551. ZHU L, Dong L, Feng M, Yang F, et al
    Profiles of autophagy-related genes in esophageal adenocarcinoma.
    BMC Cancer. 2020;20:943.
    >> Share

    September 2020
  552. ELHALAWANI H, Mohamed ASR, Elgohari B, Lin TA, et al
    Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:912.
    >> Share

  553. IZKHAKOV E, Keinan-Boker L, Barchana M, Shacham Y, et al
    Long-term all-cause mortality and its association with cardiovascular risk factors in thyroid cancer survivors: an Israeli population-based study.
    BMC Cancer. 2020;20:892.
    >> Share

  554. LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    BMC Cancer. 2020;20:886.
    >> Share

  555. YOON JY, Brezden-Masley C, Streutker CJ
    Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    BMC Cancer. 2020;20:860.
    >> Share

  556. ALMANGUSH A, Makitie AA, Hagstrom J, Haglund C, et al
    Cell-in-cell phenomenon associates with aggressive characteristics and cancer-related mortality in early oral tongue cancer.
    BMC Cancer. 2020;20:843.
    >> Share

    August 2020
  557. ZHANG B, Gao S, Li R, Li Y, et al
    Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    BMC Cancer. 2020;20:815.
    >> Share

  558. TU XP, Li H, Chen LS, Luo XN, et al
    OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
    BMC Cancer. 2020;20:794.
    >> Share

  559. ZENG H, Song X, Ji J, Chen L, et al
    HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC.
    BMC Cancer. 2020;20:796.
    >> Share

  560. CHEN C, Chen S, Cao H, Wang J, et al
    Prognostic significance of autophagy-related genes within esophageal carcinoma.
    BMC Cancer. 2020;20:797.
    >> Share

  561. LEERS JM, Knepper L, van der Veen A, Schroder W, et al
    The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    BMC Cancer. 2020;20:781.
    >> Share

  562. CIAPPUCCINI R, Heutte N, Lasne-Cardon A, Saguet-Rysanek V, et al
    Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome.
    BMC Cancer. 2020;20:765.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016